More than nine lakh Delhi residents now have a health safety net through Ayushman Bharat, with expanded insurance cover, settled claims, and affordable medicines.
A national survey finds 6 in 10 Indian men are unaware of their prostate cancer screening status, exposing major gaps in awareness and early detection.
Cancer clinical research in India needs stronger environmental exposure data to investigate possible links between air pollution and gastrointestinal cancers.
Uttar Pradesh's single-dose iron injection during pregnancy program aims to improve maternal anaemia treatment by reducing repeat visits and expanding access to intravenous iron.
Health Minister J.P. Nadda has launched JOSH Teams to boost TB elimination in India, putting fresh focus on drug demand, supply and access.
Healthcare influencer marketing faces new NMC rules as agencies, influencers, and platforms navigate stricter advertising and patient procurement restrictions.
India’s TB fight gets an AI layer as Khushi Avatar joins JOSH Teams, combining digital support with youth-led community mobilisation.
Paediatric GLP-1 drugs in India face closer scrutiny after WHO prioritised lifestyle interventions and called for stronger evidence before wider use in children.
Serum Institute’s WHO nod for Cervavac strengthens India’s cancer-free vision by expanding access to an indigenous HPV vaccine.
Tripura breast cancer screening is expanding as 58.2 percent of cases show distant metastasis, putting early detection and treatment access under focus.
.jpg)
, CDSCO.jpg)
